Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002354931 | SCV001187118 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-05-24 | criteria provided, single submitter | clinical testing | The p.F2069L variant (also known as c.6207C>G), located in coding exon 41 of the NF1 gene, results from a C to G substitution at nucleotide position 6207. The phenylalanine at codon 2069 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |